Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

140
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
140
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

188
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
188
Cancer02:18

Cancer

49.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recruitment strategies for lung cancer screening; a randomised trial in the 4-IN-THE-LUNG-RUN study.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Vulnerability factors for trauma injuries in female sexual assault patients in a diverse urban city population.

Women's health (London, England)·2026
Same author

Implementation of smoking cessation interventions in real-world lung cancer screening: a RE-AIM-guided scoping review.

Journal of the National Cancer Institute·2026
Same author

Advances in Diagnosis-Pulmonology.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Longitudinal Language-Model Reasoning Enables Automated Labeling of Lung Cancer Recurrence from Unstructured Clinical Records.

Research square·2026
Same author

Lung cancer screening in transition: highlights from the 3rd Oslo Lung Cancer Symposium, 2025.

European clinical respiratory journal·2026
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Aug 16, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K

Lung cancer screening.

Scott J Adams1, Emily Stone2, David R Baldwin3

  • 1Department of Radiology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Lancet (London, England)
|December 23, 2022
PubMed
Summary
This summary is machine-generated.

Lung cancer screening using low-dose CT significantly reduces mortality. Further research is needed to optimize screening effectiveness, cost, and accessibility for all individuals.

More Related Videos

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.4K

Related Experiment Videos

Last Updated: Aug 16, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.4K

Area of Science:

  • Pulmonology
  • Radiology
  • Oncology

Background:

  • Randomized controlled trials like NLST and NELSON demonstrate reduced lung cancer mortality with low-dose CT screening.
  • Despite proven benefits, optimal clinical and cost-effectiveness of lung cancer screening programs require further investigation.

Purpose of the Study:

  • To review current evidence on lung cancer screening.
  • To identify key areas for improving screening effectiveness, cost-effectiveness, and implementation.
  • To explore the role of AI, biomarkers, and integrated health assessments.

Main Methods:

  • Comprehensive literature review of randomized controlled trials and relevant studies.
  • Analysis of data concerning patient selection, management of findings, and smoking cessation.
  • Evaluation of cost-effectiveness, AI applications, and biomarker potential.

Main Results:

  • Low-dose CT screening reduces lung cancer mortality compared to radiography or no screening.
  • Uncertainties persist regarding optimal patient selection, screening intervals, and cost-effectiveness.
  • Artificial intelligence and biomarkers show promise for enhancing nodule detection and risk stratification.

Conclusions:

  • Lung cancer screening is effective in reducing mortality, but optimization is needed.
  • Future research should focus on risk models, personalized screening, novel biomarkers, integrated assessments, and AI.
  • Addressing implementation challenges is crucial for efficient and equitable lung cancer screening programs.